<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2575803-A4" country="EP" doc-number="2575803" kind="A4" date="20140101" family-id="45067028" file-reference-id="318292" date-produced="20180823" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146552529" ucid="EP-2575803-A4"><document-id><country>EP</country><doc-number>2575803</doc-number><kind>A4</kind><date>20140101</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-11790192-A" is-representative="NO"><document-id mxw-id="PAPP154826452" load-source="docdb" format="epo"><country>EP</country><doc-number>11790192</doc-number><kind>A</kind><date>20110520</date><lang>EN</lang></document-id><document-id mxw-id="PAPP183268026" load-source="docdb" format="original"><country>EP</country><doc-number>11790192.6</doc-number><date>20110520</date><lang>EN</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140454663" ucid="US-2011037449-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>2011037449</doc-number><kind>W</kind><date>20110520</date></document-id></priority-claim><priority-claim mxw-id="PPC140452303" ucid="US-201161449513-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>201161449513</doc-number><kind>P</kind><date>20110304</date></document-id></priority-claim><priority-claim mxw-id="PPC140450282" ucid="US-39680010-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>39680010</doc-number><kind>P</kind><date>20100602</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1988103195" load-source="docdb">A61K   9/14        20060101ALI20131120BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988107314" load-source="docdb">A61K  47/42        20060101ALI20131120BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988109013" load-source="docdb">A61K  47/48        20060101ALI20131120BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988109929" load-source="docdb">A61K  31/555       20060101ALI20131120BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988111031" load-source="docdb">A61K   9/00        20060101ALI20131120BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988123817" load-source="docdb">A61P  35/04        20060101ALI20131120BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988126284" load-source="docdb">A61K  38/38        20060101ALI20131120BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988130981" load-source="docdb">A61K  31/337       20060101AFI20131120BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988137918" load-source="docdb">A61K  31/7068      20060101ALI20131120BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL1988110692" load-source="docdb" scheme="CPC">A61K   9/0019      20130101 LI20131011BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988119331" load-source="docdb" scheme="CPC">A61K  31/337       20130101 LI20131011BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988119443" load-source="docdb" scheme="CPC">A61K  31/555       20130101 LI20131011BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988125971" load-source="docdb" scheme="CPC">A61K  31/7068      20130101 LI20131011BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988136219" load-source="docdb" scheme="CPC">A61K   9/146       20130101 LI20131011BHEP        </classification-cpc><classification-cpc mxw-id="PCL2039498268" load-source="docdb" scheme="CPC">A61K  31/282       20130101 LI20140220BHEP        </classification-cpc><classification-cpc mxw-id="PCL2039500546" load-source="docdb" scheme="CPC">A61K  38/38        20130101 FI20140228BHEP        </classification-cpc><classification-cpc mxw-id="PCL2060945928" load-source="docdb" scheme="CPC">A61K  47/42        20130101 LI20140313BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132190071" lang="DE" load-source="docdb">VERFAHREN ZUR BEHANDLUNG VON BLASENKREBS</invention-title><invention-title mxw-id="PT132190072" lang="EN" load-source="docdb">METHODS OF TREATING BLADDER CANCER</invention-title><invention-title mxw-id="PT135470769" lang="FR" load-source="docdb">PROCÉDÉ DE TRAITEMENT DU CANCER DE LA VESSIE</invention-title><citations><patent-citations><patcit mxw-id="PCIT376361259" load-source="docdb" ucid="US-20070116774-A1"><document-id format="epo"><country>US</country><doc-number>20070116774</doc-number><kind>A1</kind><date>20070524</date></document-id><sources><source name="SEA" category="XDY" created-by-npl="N"/></sources></patcit></patent-citations><non-patent-citations><nplcit><text>BARLOW L J ET AL: "Novel intravesical therapies for non-muscle-invasive bladder cancer refractory to BCG", UROLOGIC ONCOLOGY, ELSEVIER, NEW YORK, NY, US, vol. 28, no. 1, 1 January 2010 (2010-01-01), pages 108 - 111, XP026820997, ISSN: 1078-1439, [retrieved on 20091228]</text><sources><source mxw-id="PNPL56209547" load-source="docdb" name="SEA" category="XY"/></sources></nplcit><nplcit><text>CHIEN AMY J ET AL: "A Phase I Study of a 2-Day Lapatinib Chemosensitization Pulse Preceding Nanoparticle Albumin-Bound Paclitaxel for Advanced Solid Malignancies", CLINICAL CANCER RESEARCH, vol. 15, no. 17, September 2009 (2009-09-01), pages 5569 - 5575, XP002716417, ISSN: 1078-0432</text><sources><source mxw-id="PNPL56209548" load-source="docdb" name="SEA" category="XY"/></sources></nplcit><nplcit><text>KRATZ ET AL: "Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 132, no. 3, 18 December 2008 (2008-12-18), pages 171 - 183, XP025714816, ISSN: 0168-3659, [retrieved on 20081129], DOI: 10.1016/J.JCONREL.2008.05.010</text><sources><source mxw-id="PNPL56209549" load-source="docdb" name="SEA" category="Y"/></sources></nplcit><nplcit><text>See also references of WO 2011153009A1</text><sources><source mxw-id="PNPL65821930" load-source="docdb" name="SEA"/></sources></nplcit><nplcit><text>SONPAVDE GURU ET AL: "Treatment of metastatic urothelial cancer: opportunities for drug discovery and development", BJU INTERNATIONAL, vol. 102, no. 9, Part B, November 2008 (2008-11-01), pages 1354 - 1360, XP002716418, ISSN: 1464-4096</text><sources><source mxw-id="PNPL56209551" load-source="docdb" name="SEA" category="XY"/></sources></nplcit><nplcit><text>SRIDHAR, S.S.: "A phase II study of single agent abraxane as second-line therapy in pateients with advanced urothelial carcinoma", J CLIN ONCOL, vol. 27, no. suppl, abstr e16058, 21 April 2009 (2009-04-21), pages 1 - 2, XP002716416, Retrieved from the Internet &lt;URL:http://meetinglibrary.asco.org/content/33661-65&gt; [retrieved on 20131114]</text><sources><source mxw-id="PNPL56209552" load-source="docdb" name="SEA" category="XY"/></sources></nplcit><nplcit><text>THOMAS E STINCHCOMBE ET AL: "Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane(R)) on three treatment schedules in patients with solid tumors", CANCER CHEMOTHERAPY AND PHARMACOLOGY, SPRINGER, BERLIN, DE, vol. 60, no. 5, 7 February 2007 (2007-02-07), pages 759 - 766, XP019539690, ISSN: 1432-0843, DOI: 10.1007/S00280-007-0423-X</text><sources><source mxw-id="PNPL56209553" load-source="docdb" name="SEA" category="XY"/></sources></nplcit><nplcit><text>WONG J ET AL: "Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, vol. 60, no. 8, 22 May 2008 (2008-05-22), pages 939 - 954, XP022624681, ISSN: 0169-409X, [retrieved on 20080207], DOI: 10.1016/J.ADDR.2007.11.008</text><sources><source mxw-id="PNPL56209554" load-source="docdb" name="SEA" category="XY"/></sources></nplcit></non-patent-citations></citations></technical-data><parties><applicants><applicant mxw-id="PPAR918142275" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>ABRAXIS BIOSCIENCE LLC</last-name><address><country>US</country></address></addressbook></applicant><applicant mxw-id="PPAR918162368" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>ABRAXIS BIOSCIENCE, LLC</last-name></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR918151462" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>DESAI NEIL P</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918171359" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>DESAI, NEIL, P.</last-name></addressbook></inventor><inventor mxw-id="PPAR918133451" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>SOON-SHIONG PATRICK</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918167022" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>SOON-SHIONG, PATRICK</last-name></addressbook></inventor></inventors></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS548823119" load-source="docdb">AL</country><country mxw-id="DS548951120" load-source="docdb">AT</country><country mxw-id="DS548823121" load-source="docdb">BE</country><country mxw-id="DS548962081" load-source="docdb">BG</country><country mxw-id="DS548876774" load-source="docdb">CH</country><country mxw-id="DS548956455" load-source="docdb">CY</country><country mxw-id="DS548951121" load-source="docdb">CZ</country><country mxw-id="DS548823126" load-source="docdb">DE</country><country mxw-id="DS548956456" load-source="docdb">DK</country><country mxw-id="DS548956457" load-source="docdb">EE</country><country mxw-id="DS548961079" load-source="docdb">ES</country><country mxw-id="DS548962082" load-source="docdb">FI</country><country mxw-id="DS548962083" load-source="docdb">FR</country><country mxw-id="DS548823127" load-source="docdb">GB</country><country mxw-id="DS548956458" load-source="docdb">GR</country><country mxw-id="DS548823128" load-source="docdb">HR</country><country mxw-id="DS548951126" load-source="docdb">HU</country><country mxw-id="DS548876775" load-source="docdb">IE</country><country mxw-id="DS548823129" load-source="docdb">IS</country><country mxw-id="DS548962084" load-source="docdb">IT</country><country mxw-id="DS548956459" load-source="docdb">LI</country><country mxw-id="DS548949177" load-source="docdb">LT</country><country mxw-id="DS548951127" load-source="docdb">LU</country><country mxw-id="DS548949178" load-source="docdb">LV</country><country mxw-id="DS548949179" load-source="docdb">MC</country><country mxw-id="DS548848338" load-source="docdb">MK</country><country mxw-id="DS548848339" load-source="docdb">MT</country><country mxw-id="DS548961080" load-source="docdb">NL</country><country mxw-id="DS548962085" load-source="docdb">NO</country><country mxw-id="DS548961081" load-source="docdb">PL</country><country mxw-id="DS548876776" load-source="docdb">PT</country><country mxw-id="DS548961086" load-source="docdb">RO</country><country mxw-id="DS548876777" load-source="docdb">RS</country><country mxw-id="DS548961087" load-source="docdb">SE</country><country mxw-id="DS548876778" load-source="docdb">SI</country><country mxw-id="DS548848340" load-source="docdb">SK</country><country mxw-id="DS548848341" load-source="docdb">SM</country><country mxw-id="DS548956460" load-source="docdb">TR</country></ep-contracting-states><ep-extended-states><ep-extended-state-data><country>BA</country></ep-extended-state-data><ep-extended-state-data><country>ME</country></ep-extended-state-data></ep-extended-states></designated-states></international-convention-data></bibliographic-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
